Leucine metabolism in rats with cirrhosis

Journal of Hepatology

Volumn 24, Issue 2, 1996, Pages 209-216

  Holeček, Milan ^a   Tilšer, Ivan ^a   Skopec, Frantisek ^b   Šprongl, Ludek ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Radioisotope Laboratory   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Branched chain amino acids; Cirrhosis; Ketoisocaproate; Leucine; Protein metabolism

Indexed keywords

BRANCHED CHAIN AMINO ACID; CARBON TETRACHLORIDE; ISOLEUCINE; LEUCINE; VALINE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LIVER CIRRHOSIS; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT;

EID: 2542507703     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80031-6     Document Type: Article

References (48)

1. Flock EV, Mann FC, Bollman JL. Free amino acids in plasma and muscle following total removal of the liver. J Biol Chem 1951; 192: 293-300.
2. Iber FL, Rosen H, Levenson SM, Chalmers TC. The plasma amino acids in patients with liver failure. J Lab Clin Med 1957; 50: 417-25.
3. Fischer JE, Funovics J, Aguirre A, James JH, Keane JM, Wesdorp RIC, Yoshimura N, Westham T. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975; 78: 276-90.
4. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976; 80: 77-91.
5. Watanabe A, Shiota T, Okita H, Nagashima H. Effect of branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis. Acta Med Okayama 1983; 37: 321-33.
6. Morgan MY. Branched chain amino acids in the management of chronic liver disease. Facts and fantasies. J Hepatol 1990: 11: 133-41.
7. Bianchi GP, Marchesini G, Zoli M, Abbiati R, Ferrario E, Fabbri A, Pisi E. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels. Hepato-Gastroenterology 1992; 39: 443-6.
8. Rigotti P, Peters JC, Tranberg KO, Fischer JE. Effect of amino acid infusions on liver regeneration after partial hepatectomy in the rat. J Parenter Enter Nutr 1986; 10: 17-20.
9. Holeček M, Šimek J, Palička V, Zadák Z. Effect of glucose and branched chain amino acid infusion on onset of liver regeneration and plasma amino acid pattern in partially hepatectomized rats. J Hepatol 1991; 13: 14-20.
10. Kanematsu T, Koyanagi N, Matsumata T, Kitano S, Takenaka K, Sugimachi K. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial. Surgery 1988; 104: 482-8.
11. Vilstrup H, Gluud C, Hardt F, Kristensen M, Kohler O, Melgaard B, Dejgaard A, Hansen BA, Krintel JJ, Schütten HJ, Thommsen AC. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. J Hepatol 1990; 10: 291-6.
12. Vilstrup H, Bucher D, Krog B, Damgard SE. Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver. Eur J Clin Invest 1982; 12: 197-202.
13. O'Keefe S, Abraham R, Davis M, Williams R. Protein turnover in acute and chronic liver disease. Acta Chir Scand 1980; 507: 91-100.
14. Blonde-Cynober F, Plassart F, Rey C, Coudray-Lucas C, Moukarbel N, Poupon R, Giboudeau J, Cynober L. Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease. Ann Nutr Metab 1994; 38: 238-48.
15. Swart GR, van den Berg JWO, Wattimena JLD, Rietveld T, van Vuure JK, Frenkel M. Elevated protein requirements in cirrhosis of the liver investigated by whole-body protein turnover studies. Clin Sci 1988; 75: 101-7.
16. Holdsworth JD, Dionigi P, Clague MB, James OFW, Wright PD. Body protein metabolism and plasma amino acids in cirrhosis of the liver. The effect of varying the branched chain amino acid content of intravenous amino acid solutions. Clin Nutr 1984; 3: 153-62.
17. Millikan WJ, Henderson JM, Galloway JR, Warren WD, Matthews DE, McGhee A, Kutner MH. In vivo measurement of leucine metabolism with stable isotopes in normal subjects and in those with cirrhosis fed conventional and branched-chain amino acid-enriched diets. Surgery 1985; 98: 405-12.
18. Mullen KD, Denne SC, McCullough AJ, Savin SM, Bruno D, Tavill AS, Kalhan SC. Leucine metabolism in stable cirrhosis. Hepatology 1986; 6: 622-63.
19. Merli M, Riggio O, Romiti A, Ariosto F, Mango L, Pinto G, Savioli M, Capocaccia L. Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology 1990; 12: 106-12.
20. Iob V, Coon WW, Sloan M. Altered clearance of free amino acids from plasma of patients with cirrhosis of the liver. J Surg Res 1966; 6: 223-39.
21. Elia M, Farrell R, Ilic V, Smith R, Williamson DH. The removal of infused leucine after injury, starvation, and other conditions in man. Clin Sci. 1980; 59: 275-83.
22. Schauder P, Schröder K, Herbertz L, Langer K, Langenbeck U. Evidence for valine intolerance in patients with cirrhosis. Hepatology 1984; 4: 667-70.
23. Ferenci P, Bratusch-Marrain P, Waldhäusl K, Nowotny P, Korn A. Impaired plasma amino-acid clearance in patients with cirrhosis of the liver and portocaval shunt - its relation to insulin resistance. Eur J Clin Invest 1984; 14: 255-61.
24. Marchesini G, Bianchi G, Zoli M, Dondi C, Forlani G, Melli A, Bua V, Vannini P, Pisi E. Plasma amino acid response to protein ingestion in patients with liver cirrhosis. Gastroenterology 1983; 85: 283-90.
25. Marchesini G, Bianchi G, Vilstrup H, Checchia GA, Patrono D, Zoli M. Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis. J Hepatol 1987; 4: 108-17.
26. Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Ann Rev Nutr 1984; 4: 409-54.
27. Blonde-Cynober F, De Bandt JP, Ballet F, Rey C, Coudray-Lucas C, Josset P, Giboudeau J, Cynober L. Branched-chain amino acid metabolism in isolated perfused liver of cirrhotic rats. Scand J Gastroenterol 1992; 27: 391-6.
28. de Boer JEG, Goossens HM, van Dongen JJ, van Eyck HMH, Janssen MA, van Leeuwen PAM, Soeters PB. Activity of branched-chain oxo-acid dehydrogenase (BCOA-DH) in adipose tissue and diaphragm of rats: the influence of portacaval shunt (PCS). In: Kleinberger G, Ferenci P, Riederer P, Thaler H, eds. Advances in Hepatic Encephalopathy and Urea Cycle Diseases. Basel: Karger, 1984; 555-62.
29. Vazquez JA, Morse EL, Adibi SA. Effect of dietary fat, carbohydrate, and protein on branched-chain amino acid catabolism during caloric restriction. J Clin Invest 1985; 76: 737-43.
30. Hutson SM, Cree TC, Harper AE. Regulation of leucine and α-ketoisocaproate metabolism in skeletal muscle. J Biol Chem 1978; 253: 8126-33.
31. Patel TB, DeBuysere MS, Barron LL, Olson MS. Studies on the regulation of the branched chain α-keto acid dehydrogenase in the perfused rat liver. J Biol Chem 1981; 256: 9009-15.
32. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
33. Ariosto F, Riggio C, Cantafora A, Colucci S, Gaudio E, Mechelli C, Merli M, Seri S, Capocaccia L. Carbon tetrachloride-induced experimental cirrhosis in the rat: a reappraisal of the model. Eur Surg Res 1989; 21: 280-6.
34. 4-induced liver cirrhosis. Life Sci 1994; 54: 2071-82.
35. McCullough AJ, Mullen KD, Tavill AS, Kalhan SC. In vivo differences between the turnover rates of leucine and leucine's ketoacid in stable cirrhosis. Gastroenterology 1992; 103: 571-8.
36. Zoli M, Marchesini G, Dondi C, Bianchi GP, Pisi E. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting. Clin Sci 1982; 62: 683-6.
37. Emery PW, Cotellessa L, Holness M, Egan C, Rennie MJ. Different patterns of protein turnover in skeletal and gastrointestinal smooth muscle and the production of N-methylhistidine during fasting in the rat. Biosci Rep 1986; 6: 143-53.
38. Bosari S, Marradi C, Chiara O, Bevilacqua G, Nespoli A. Energy expenditure in cirrhotic patients. In: Kleinberger G, Ferenci P, Riederer P, Thaler H, eds. Advances in Hepatic Encephalopathy and Urea Cycle Diseases. Basel: Karger, 1984; 674-81.
39. Müller MJ, Lautz HU, Plogmann B, Bürger M, Kürber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15: 782-94.
40. Merli M, Eriksson LS, Hagenfeldt L, Wahren J. Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis. J Hepatol 1986; 3: 348-55.
41. Romjin JA, Endert E, Sauerwein HP. Glucose and fat metabolism during short-term starvation in cirrhosis. Gastroenterology 1991; 100: 731-7.
42. Beaufrere B, Tessari P, Cattalini M, Miles J, Haymond HW. Apparent decrease in oxidation and turnover of leucine during infusion of medium chain triglycerides. Am J Physiol 1985; 249: E175-82.
43. Sherwin RS, Hendler RG, Felig P. Effect of ketone infusion on amino acid and nitrogen metabolism in man. J Clin Invest 1975; 55: 1382-90.
44. Clowes GHA, McDermott WV, Williams LF, Loda M, Menzoian JO, Pearl R. Amino acid clearance and prognosis in surgical patients with cirrhosis. Surgery 1984; 96: 675-84.
45. Soeters PB, de Boer J. Why are plasma branched chain amino acid levels diminished in patients with liver cirrhosis? In: Kleinberger G, Ferenci P, Riederer P, Thaler H, eds. Branched Chain Amino and Keto Acids in Health and Disease. Basel: Karger, 1984; 483-96.
46. Frick GP, Goodman HM. Insulin regulation of branched-chain α-keto dehydrogenase in adipose tissue. J Biol Chem 1980; 255: 6181-92.
47. Ichihara A, Takahashi H, Aki K, Shirai A. Transaminase of branched-chain amino acids. II. Physiological change in enzyme activity in rat liver and kidney. Biochem Biophys Res Commun 1967; 26: 674-8.
48. Nygren A, Adner N, Sundblad L, Wiechel KL. Insulin uptake by human alcoholic liver. Metabolism 1985; 34: 48-52.